Period | B | T | F | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Week | Â | 1 | 2 | 3 | 4 | 8 | 12 | ||||
Informed consent | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Demographic characteristics | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
EA/Sham EA treatment | Â | x | x | x | x | x | x | x | x | Â | Â |
EORTC QLQ-CIPN20 | x | Â | Â | Â | x | Â | Â | Â | x | x | x |
NRS | x | x | x | x | x | x | x | x | x | x | x |
SWM test | x | Â | Â | Â | x | Â | Â | Â | x | x | x |
NCS | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | x |
EORTC QLQ-C30 | x | Â | Â | Â | x | Â | Â | Â | x | x | x |
PGIC | Â | Â | Â | Â | Â | Â | Â | Â | x | x | x |
Safety assessment | Â | x | x | x | x | x | x | x | x | x | x |